Acorda Therapeutics | Koszty Sprzedaży



Cost Of Sales Zmiana Data
Acadia Pharmaceuticals USD 20.39M 1.41M 2025-03
Agios Pharmaceuticals USD 1.08M 175K 2025-03
ALKERMES USD 49.2M 12.92M 2025-03
Amgen USD 2.6B 507M 2025-03
Biogen USD 629.3M 45.8M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Cipla INR 21.89B 750.6M 2025-03
Clal Biotechnology ILS 16.49M 2.64M 2022-06
Compugen USD 675K 2.93M 2024-12
CSL USD 3.93B 527M 2024-12
Cytokinetics 463K 79.14M 2024-09
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Grifols EUR 1.21B 143.12M 2024-12
Halozyme Therapeutics USD 48.4M 6.35M 2025-03
Insmed USD 21.28M 4.87M 2025-03
Ligand Pharmaceuticals USD 4.85M 2.01M 2025-03
MannKind USD 17.02M 588K 2025-03
Merck EUR 2.14B 184M 2025-03
Moderna USD 90M 456M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Novartis USD 3.32B 90M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Sanofi EUR 2.89B 618M 2025-03
Teva Pharmaceutical Industries USD 1.98B 132M 2025-03
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Acorda Therapeutics Koszty Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.